幹細胞治療の世界市場 - 市場規模（タイプ別、治療領域別、最終用途別）、業界分析、地域の見通し、成長可能性、競合の市場シェア、予測（2023年～2032年）

世界の幹細胞治療市場は、再生医療における持続的な技術革新により、2032年まで顕著な成長を示すと予測されています。

当レポートでは、世界の幹細胞治療市場について調査分析し、業界の考察、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 幹細胞治療業界の考察

• 業界セグメンテーション
• 業界情勢（2018年～2032年）
• 業界に対する影響要因
  • 成長促進要因
  • 業界の潜在的リスク・課題
• 成長可能性分析
  • タイプ別
  • 治療領域別
  • 最終用途別
• COVID-19の影響の分析
• 幹細胞治療のエコシステム分析
• 規制情勢
  • 米国
  • 欧州
  • アジア太平洋
• 幹細胞の由来
  • 間葉系幹細胞（MSC）
  • 造血幹細胞（HSC）
  • 胚性幹細胞（ESC）
  • 人工多能性幹細胞（iPSC）
• ポーターのファイブフォース分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 競合ポジショニングマトリックス
• 戦略ダッシュボード

第5章 幹細胞治療市場：タイプ別

• 主なタイプの動向
• 同種幹細胞治療
• 自家幹細胞治療

第6章 幹細胞治療市場：治療領域別

• 主な治療領域の動向
• 腫瘍
• 整形外科
• 心血管
• 神経

第7章 幹細胞治療市場：最終用途別

• 主な最終用途の動向
• 病院
• 診療所
• 整形外科

第8章 幹細胞治療市場：地域別

• 主な地域の動向
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • ロシア
  • ポーランド
  • スイス
  • オランダ
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
  • シンガポール
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • メキシコ
  • チリ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル

第9章 企業プロファイル

• Astellas Pharma Inc
• CHIESI Farmaceutici S.p.A.
• Capricor Therapeutics
• Cellectis
• Fujifilm Cellular Dynamics
• GSK plc.
• ThermoGenesis Holdings, Inc
• DiscGenics
• Mesoblast Ltd
• Novadip Biosciences
• MEDIPOST
• Takeda Pharmaceuticals
• Celyad
• Gamida Cell
• ReNeuron Group plc

Data Tables

• TABLE 1. Global stem cell market, 2018 - 2022 (USD Million)
• TABLE 2. Global stem cell market, 2023 - 2032 (USD Million)
• TABLE 3. Global stem cell market, by type, 2018 - 2022 (USD Million)
• TABLE 4. Global stem cell market, by type, 2023 - 2032 (USD Million)
• TABLE 5. Global stem cell market, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 6. Global stem cell market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 7. Global stem cell market, by end-use, 2018 - 2022 (USD Million)
• TABLE 8. Global stem cell market, by end-use, 2023 - 2032 (USD Million)
• TABLE 9. Global stem cell market, by region, 2018 - 2022 (USD Million)
• TABLE 10. Global stem cell market, by region, 2023 - 2032 (USD Million)
• TABLE 11. Industry impact forces
• TABLE 12. Allogenic stem cell therapy market size, 2018 - 2022 (USD Million)
• TABLE 13. Allogenic stem cell therapy market size, 2023 - 2032 (USD Million)
• TABLE 14. Autologous stem cell therapy market size, 2018 - 2022 (USD Million)
• TABLE 15. Autologous stem cell therapy market size, 2023 - 2032 (USD Million)
• TABLE 16. Oncology market size, 2018 - 2022 (USD Million)
• TABLE 17. Oncology market size, 2023 - 2032 (USD Million)
• TABLE 18. Orthopedic market size, 2018 - 2022 (USD Million)
• TABLE 19. Orthopedic market size, 2023 - 2032 (USD Million)
• TABLE 20. Cardiovascular market size, 2018 - 2022 (USD Million)
• TABLE 21. Cardiovascular market size, 2023 - 2032 (USD Million)
• TABLE 22. Neurology market size, 2018 - 2022 (USD Million)
• TABLE 23. Neurology market size, 2023 - 2032 (USD Million)
• TABLE 24. Others market size, 2018 - 2022 (USD Million)
• TABLE 25. Others market size, 2023 - 2032 (USD Million)
• TABLE 26. Hospitals market size, 2018 - 2022 (USD Million)
• TABLE 27. Hospitals market size, 2023 - 2032 (USD Million)
• TABLE 28. Clinics market size, 2018 - 2022 (USD Million)
• TABLE 29. Clinics market size, 2023 - 2032 (USD Million)
• TABLE 30. Others market size, 2018 - 2022 (USD Million)
• TABLE 31. Others market size, 2023 - 2032 (USD Million)
• TABLE 32. North America stem cell market size, by country, 2018 - 2022 (USD Million)
• TABLE 33. North America stem cell market size, by country, 2023 - 2032 (USD Million)
• TABLE 34. North America stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 35. North America stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 36. North America stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 37. North America stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 38. North America stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 39. North America stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 40. U.S. stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 41. U.S. stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 42. U.S. stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 43. U.S. stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 44. U.S. stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 45. U.S. stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 46. Canada stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 47. Canada stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 48. Canada stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 49. Canada stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 50. Canada stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 51. Canada stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 52. Europe stem cell market size, by country, 2018 - 2022 (USD Million)
• TABLE 53. Europe stem cell market size, by country, 2023 - 2032 (USD Million)
• TABLE 54. Europe stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 55. Europe stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 56. Europe stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 57. Europe stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 58. Europe stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 59. Europe stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 60. Germany stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 61. Germany stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 62. Germany stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 63. Germany stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 64. Germany stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 65. Germany stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 66. UK stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 67. UK stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 68. UK stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 69. UK stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 70. UK stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 71. UK stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 72. France stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 73. France stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 74. France stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 75. France stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 76. France stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 77. France stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 78. Italy stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 79. Italy stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 80. Italy stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 81. Italy stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 82. Italy stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 83. Italy stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 84. Spain stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 85. Spain stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 86. Spain stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 87. Spain stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 88. Spain stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 89. Spain stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 90. Russia stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 91. Russia stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 92. Russia stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 93. Russia stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 94. Russia stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 95. Russia stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 96. Poland stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 97. Poland stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 98. Poland stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 99. Poland stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 100. Poland stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 101. Poland stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 102. Switzerland stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 103. Switzerland stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 104. Switzerland stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 105. Switzerland stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 106. Switzerland stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 107. Switzerland stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 108. Netherlands stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 109. Netherlands stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 110. Netherlands stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 111. Netherlands stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 112. Netherlands stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 113. Netherlands stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 114. Asia Pacific stem cell market size, by country, 2018 - 2022 (USD Million)
• TABLE 115. Asia Pacific stem cell market size, by country, 2023 - 2032 (USD Million)
• TABLE 116. Asia Pacific stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 117. Asia Pacific stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 118. Asia Pacific stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 119. Asia Pacific stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 120. Asia Pacific stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 121. Asia Pacific stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 122. Japan stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 123. Japan stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 124. Japan stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 125. Japan stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 126. Japan stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 127. Japan stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 128. China stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 129. China stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 130. China stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 131. China stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 132. China stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 133. China stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 134. India stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 135. India stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 136. India stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 137. India stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 138. India stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 139. India stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 140. Australia stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 141. Australia stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 142. Australia stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 143. Australia stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 144. Australia stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 145. Australia stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 146. Singapore stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 147. Singapore stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 148. Singapore stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 149. Singapore stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 150. Singapore stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 151. Singapore stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 152. Thailand stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 153. Thailand stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 154. Thailand stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 155. Thailand stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 156. Thailand stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 157. Thailand stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 158. South Korea stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 159. South Korea stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 160. South Korea stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 161. South Korea stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 162. South Korea stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 163. South Korea stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 164. Latin America stem cell market size, by country, 2018 - 2022 (USD Million)
• TABLE 165. Latin America stem cell market size, by country, 2023 - 2032 (USD Million)
• TABLE 166. Latin America stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 167. Latin America stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 168. Latin America stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 169. Latin America stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 170. Latin America stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 171. Latin America stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 172. Brazil stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 173. Brazil stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 174. Brazil stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 175. Brazil stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 176. Brazil stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 177. Brazil stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 178. Mexico stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 179. Mexico stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 180. Mexico stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 181. Mexico stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 182. Mexico stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 183. Mexico stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 184. Chile stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 185. Chile stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 186. Chile stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 187. Chile stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 188. Chile stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 189. Chile stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 190. Argentina stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 191. Argentina stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 192. Argentina stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 193. Argentina stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 194. Argentina stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 195. Argentina stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 196. MEA stem cell market size, by country, 2018 - 2022 (USD Million)
• TABLE 197. MEA stem cell market size, by country, 2023 - 2032 (USD Million)
• TABLE 198. MEA stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 199. MEA stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 200. MEA stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 201. MEA stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 202. MEA stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 203. MEA stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 204. South Africa stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 205. South Africa stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 206. South Africa stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 207. South Africa stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 208. South Africa stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 209. South Africa stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 210. Saudi Arabia stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 211. Saudi Arabia stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 212. Saudi Arabia stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 213. Saudi Arabia stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 214. Saudi Arabia stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 215. Saudi Arabia stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 216. UAE stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 217. UAE stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 218. UAE stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 219. UAE stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 220. UAE stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 221. UAE stem cell market size, by end-use, 2023 - 2032 (USD Million)
• TABLE 222. Israel stem cell market size, by type, 2018 - 2022 (USD Million)
• TABLE 223. Israel stem cell market size, by type, 2023 - 2032 (USD Million)
• TABLE 224. Israel stem cell market size, by therapeutic area, 2018 - 2022 (USD Million)
• TABLE 225. Israel stem cell market size, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 226. Israel stem cell market size, by end-use, 2018 - 2022 (USD Million)
• TABLE 227. Israel stem cell market size, by end-use, 2023 - 2032 (USD Million)

Charts & Figures

• Fig.1 Industry segmentation
• Fig.2 Top-down approach
• Fig.3 Breakdown of primary participants
• Fig.4 Stem cell therapy industry 360 degree synopsis, 2018 - 2032
• Fig.5 Industry landscape, 2018 - 2032
• Fig.6 Growth potential analysis, by type
• Fig.7 Growth potential analysis, by therapeutic area
• Fig.8 Growth potential analysis, by end-use
• Fig.9 Ecosystem analysis
• Fig.10 Porter's analysis
• Fig.11 PESTEL analysis
• Fig.12 Company matrix analysis, 2021
• Fig.13 Competitive positioning matrix
• Fig.14 Strategic dashboard

Stem Cell Therapy Market is slated to depict noticeable growth through 2032 owing to the constant technological innovations in regenerative medicine therapy. Scientists and researchers have constantly been working on developing stem cell therapies that are highly effective in treating diseases whose cure has not been found yet.

Stem cell therapy accelerates the repair response of diseased, injured, or dysfunctional tissues with the help of stem cells or their derivatives. It offers natural growth factors that help the body boost its healing response, while lowering the pain caused due to an injury or a disease. In addition, several benefits offered by the therapy, such as effectively reducing pain, minimal post-procedural recovery, increased functionality and flexibility, avoiding surgery and its risks of complications, and prevention of nerve damage, are slated to spur its adoption during the estimated timeframe.

Overall, the stem cell therapy industry is segmented in terms of type, therapeutic area, end-use, and region.

Based on type, the autologous stem cell therapy segment is slated to witness growth during the forecast time, given its ability to eliminate the need for finding a donor and reducing the overall cost. Besides, the therapy offers high compatibility with the human immune system. In addition, the risk of graft rejection is also lower, which accelerates is adoption significantly.

By therapeutic area, the oncology segment held over 37% of the market share in 2022 and is estimated to register notable gains through 2032. Constantly rising cases of cancer coupled with a high success rate of stem cell therapies will assist the segment in growing in the future. According to the WHO, cancer is one of the leading causes of deaths worldwide, accounting for 10 million deaths in 2020.

In terms of end-use, the clinics segment will exhibit over 10% CAGR between 2023-2032. The market demand is expected to be driven by the rising preference for stem cell therapies in the clinics as they are equipped with superior medical devices and superior quality reagents required for imparting stem cell therapies.

Regionally, the North America stem cell therapy market held over 41% market share in. The region will witness massive growth by 2032 owing to the rising incidences of chronic diseases such as cancer and increasing research and development practices. According to credible reports, as of January 2022, there are estimated 18.1 million cancer survivors in the United States. Besides, the key players in the region are also introducing novel stem cell therapies to offer better treatment for these diseases, which is anticipated to influence the overall regional outlook positively.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Methodology
• 1.2 Market scope and definition
• 1.3 Base estimates and working
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Stem cell therapy industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Type trends
  • 2.1.3 Therapeutic area trends
  • 2.1.4 End-use trends
  • 2.1.5 Regional trends

Chapter 3 Stem Cell Therapy Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2018 - 2032
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Advancements in regenerative medicine in North America & Europe
    • 3.3.1.2 Increasing government initiatives for stem cell therapy in developed as well as developing countries
    • 3.3.1.3 Rising awareness regarding availability of stem cell therapy in developing countries
    • 3.3.1.4 Growing prevalence of chronic diseases
    • 3.3.1.5 Increasing research and development activities undertaken by companies for stem cell therapy
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 High cost of stem cell therapy
    • 3.3.2.2 Ethical issues associated with stem cell therapy
• 3.4 Growth potential analysis
  • 3.4.1 By type
  • 3.4.2 By therapeutic area
  • 3.4.3 By end-use
• 3.5 COVID-19 impact analysis
• 3.6 Stem cell therapy ecosystem analysis
• 3.7 Regulatory landscape
  • 3.7.1 U.S.
  • 3.7.2 Europe
  • 3.7.3 Asia Pacific
• 3.8 Stem cell source
  • 3.8.1 Mesenchymal stem cells (MSCs)
  • 3.8.2 Hematopoietic stem cells (HSCs)
  • 3.8.3 Embryonic stem cells (ESCs)
  • 3.8.4 Induced pluripotent stem cells (iPSCs)
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy dashboard

Chapter 5 Stem Cell Therapy Market, By Type

• 5.1 Key type trends
• 5.2 Allogenic stem cell therapy
  • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.3 Autologous stem cell therapy
  • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Stem Cell Therapy Market, By Therapeutic Area

• 6.1 Key therapeutic area trends
• 6.2 Oncology
  • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.3 Orthopedic
  • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.4 Cardiovascular
  • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.5 Neurology
  • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.6 Orthopedic
  • 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Stem Cell Therapy Market, By End-use

• 7.1 Key end-use trends
• 7.2 Hospitals
  • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.3 Clinics
  • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.4 Orthopedic
  • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Stem Cell Therapy Market, By Region

• 8.1 Key regional trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Russia
  • 8.3.7 Poland
  • 8.3.8 Switzerland
  • 8.3.9 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Thailand
  • 8.4.7 Singapore
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Argentina
  • 8.5.3 Mexico
  • 8.5.4 Chile
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Israel

Chapter 9 Company Profiles

• 9.1 Astellas Pharma Inc
• 9.2 CHIESI Farmaceutici S.p.A.
• 9.3 Capricor Therapeutics
• 9.4 Cellectis
• 9.5 Fujifilm Cellular Dynamics
• 9.6 GSK plc.
• 9.7 ThermoGenesis Holdings, Inc
• 9.8 DiscGenics
• 9.9 Mesoblast Ltd
• 9.10 Novadip Biosciences
• 9.11 MEDIPOST
• 9.12 Takeda Pharmaceuticals
• 9.13 Celyad
• 9.14 Gamida Cell
• 9.15 ReNeuron Group plc